Australian radio therapeutics company Radiopharm Theranostics (ASX:RAD) has announced it expects to obtain a secondary listing on the Nasdaq Capital Market by the end of 2024.
Radiopharm Theranostics targets Nasdaq listing by the end of 2024
July 29, 2024 Latest NewsAustralian BiotechLatest Video
New Stories
-
Amplia announces capital raise to support the completion of Phase 2a ACCENT tr
October 30, 2024 - - Australian Biotech -
Priceline Pharmacy launches a refreshed brand strategy
October 30, 2024 - - Latest News -
Vaccine procurement and rollout was slow, but reduced the number of deaths
October 30, 2024 - - Latest News -
Boehringer Ingelheim leader promoted to global role
October 30, 2024 - - Latest News -
At least this means the industry will never again take lectures on these issues
October 29, 2024 - - Latest News -
Decisions taken during the caretaker period are governed by a formal convention
October 29, 2024 - - Latest News -
Community pharmacy leads nationwide transformation of women’s health services
October 29, 2024 - - Latest News